Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: Symposium summary

Canadian Journal of Surgery

Volumn 44, Issue 1, 2001, Pages 25-32

  Pasieka, J L ^a   McKinnon, J G ^a   Kinnear, S ^a   Yelle, C A ^a   Numerow, L ^a   Paterson, A ^a   Rorstad, O ^a   DiFrancesco, L M ^a   McEwan, A ^a   Skogseid, B ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOID SYNDROME; GASTROINTESTINAL TUMOR; HORMONAL THERAPY; PATIENT REFERRAL; PATIENT SELECTION; RADIODIAGNOSIS; SYMPOSIUM; TREATMENT INDICATION; TREATMENT PLANNING; WORKSHOP;

ALGORITHMS; APPENDICEAL NEOPLASMS; CARCINOID TUMOR; GASTROINTESTINAL NEOPLASMS; HUMANS; HYDROXYINDOLEACETIC ACID; LIVER NEOPLASMS; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035109775     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Clinical manifestations of carcinoid disease
2. Carcinoid tumours and the carcinoid syndrome
3. Carcinoid tumours: Development of our knowledge
4. The APUD concept and hormone production
5. Disorders of vasodilator hormones: Carcinoid syndrome and mastocytosis
6. Urinary 5-HT in the diagnosis of carcinoid tumours
7. Secretion of chromogranin A by peptide-producing endocrine neoplasms
8. Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones
9. Carcinoid tumour of the small bowel
10. The roentgenologic spectrum of small intestinal carcinoma tumours
11. Computed tomography of abdominal carcinoid tumours
12. Calcification and fibrosis in mesenteric carcinoid tumor. CT findings and pathologic correlation
13. Carcinoid metastases to the liver: Role of triple-phase helical CT
14. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): A comparative study with CT and MR imaging
15. Diagnostic advances in APUDomas and other endocrine tumors: Imaging and localization
16. Value of somatostatin receptor scintigraphy for preoperative localization of carcinoids
17. Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide
18. Somatostatin receptor imaging in patients with neuroendocrine tumors: Preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector
19. Intraoperative localization of gut endocrine tumours with radiolabeled somatostatin analogs and a gamma-detecting probe
20. Treatment of endocrine tumours of the pancreas
21. Carcinoid disease
22. Carcinoid tumour
23. Management of carcinoid tumours of the stomach, duodenum and pancreas
24. Gastrointestinal carcinoid tumours
25. Surgical management for carcinoid tumours of small bowel, appendix, colon and rectum
26. Carcinoid tumours. An analysis of 2,837 cases
27. Treatment of liver metastases of carcinoid tumours
28. Hepatic resection for metastatic neuroendocrine carcinomas
29. Isolated liver metastases from neuroendocrine tumours: Does resection prolong survival?
30. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumours
31. Cryosurgery for malignant tumours of the liver
32. Cryosurgical palliation of metastatic neuroendocrine tumours resistant to conventional therapy
33. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases
34. An appraisal of percutaneous treatment of liver metastases
35. Results of liver transplantation in the treatment of metastatic neuroendocrine tumours. A 31-case French multicentric report
36. The management of patients with advanced carcinoid tumours and islet cell carcinomas
37. Hepatic arterial chemoembolization for metastatic endocrine tumours
38. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumours. A prospective phase II study in 24 patients
39. Management of gastroenteropancreatic endocrine tumours; the place of somatostatin analogues
40. Treatment of the carcinoid syndrome with longacting somatostatin analogue lanreotide: A prospective study in 39 patients
41. Medical management of metastasizing carcinoid tumours
42. Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1] octreotide
43. Palliative effect Of MIBG in metastatic carcinoid tumours
44. Yttrium-90 labelled somatostatin analogue for cancer treatment
45. Streptozotocin-doxorubicin, streptozotocin-flurouracil, or chloroztocin in the treatment of advanced islet-cell tumours
46. Streptozocin plus fluorourcil versus doxorubicin therapy for metastatic carcinoid tumours
47. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors
48. The role of interferons in the management of carcinoid tumours
49. Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours
50. Combination therapy with octreotide and alpha-interferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumours
51. Interferons alone in combination with chemotherapy or other biologicals in the treatment of neuroendocrine gut and pancreatic tumours
52. A pilot study of combination therapy with interferon alpha and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumours